Journal of Renal Nutrition
Volume 15, Issue 1 , Pages 8-12 , January 2005

Inflammation and carnitine in hemodialysis patients

  • Giovanni Pertosa, MD

      Affiliations

    • Division of Nephrology, Dialysis and Transplantation, Department of Emergency and Transplantation, University of Bari, Bari, Italy.
    • Corresponding Author InformationAddress reprint requests to Giovanni Pertosa, MD, Division of Nephrology, Dialysis and Transplantation, DETO, University of Bari, Policlinico, Piazza G. Cesare 11, 70124, Bari, Italy.
    • ,
  • Giuseppe Grandaliano, MD

      Affiliations

    • Division of Nephrology, Dialysis and Transplantation, Department of Emergency and Transplantation, University of Bari, Bari, Italy.
    • ,
  • Simona Simone, MD

      Affiliations

    • Division of Nephrology, Dialysis and Transplantation, Department of Emergency and Transplantation, University of Bari, Bari, Italy.
    • ,
  • Michela Soccio, PhD

      Affiliations

    • Division of Nephrology, Dialysis and Transplantation, Department of Emergency and Transplantation, University of Bari, Bari, Italy.
    • ,
  • Francesco Paolo Schena, MD

      Affiliations

    • Division of Nephrology, Dialysis and Transplantation, Department of Emergency and Transplantation, University of Bari, Bari, Italy.

References 

  1. Gesualdo L , Pertosa G , Grandaliano G , et al.   Cytokines and bioincompatibility . Nephrol Dial Transplant . 1998;13:1622–1626
  2. Stenvinkel P , Alvestrand A . Inflammation in end-stage renal disease (Sources, consequences, and therapy) . Semin Dial . 2002;15:329–337
  3. Pertosa G , Grandaliano G , Gesualdo L , et al.   Clinical relevance of cytokine production in hemodialysis . Kidney Int . 2000;76(suppl):S104–S111
  4. Mercier E , Branger B , Vecina F , et al.   Tissue factor coagulation pathway and blood cells activation state in renal insufficiency . Hematol J . 2001;2:18–25
  5. Kato A , Odamaki M , Takita T , et al.   Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients . Kidney Int . 2002;61:1143–1152
  6. Libby P , Ridker PM , Maseri A . Inflammation and atherosclerosis . Circulation . 2002;105:1135–1143
  7. Pertosa G , Grandaliano G , Gesualdo L , et al.   Interleukin-6, interleukin-8 and monocyte chemotactic peptide-1 gene expression and protein synthesis are independently modulated by hemodialysis membranes . Kidney Int . 1998;54:570–579
  8. Viedt C , Dechend R , Fei J , et al.   MCP-1 induces inflammatory activation of human tubular epithelial cells (Involvement of the trancription factors, nuclear factor-κB and activating protein-1) . J Am Soc Nephrol . 2002;13:1534–1547
  9. Memoli B , Postiglione L , Cianciaruso B , et al.   Role of different dialysis membranes in the release of interleukin 6 soluble receptor in uremic patients . Kidney Int . 2000;58:417–424
  10. Frieling JTM , van Hamersvelt HW , Wijdenes J , et al.   Circulating concentrations of soluble interleukin 6 receptors gp80 and gp130 in chronic renal failure and effects of renal replacement therapy . Am J Nephrol . 1999;19:571–575
  11. Pelmutter RM , Levin SD , Appleby MW , et al.   Regulation of lymphocyte function by protein phosphorylation . Annu Rev Immunol . 1993;11:451–499
  12. Imada K , Leonard WJ . The Jak-STAT pathway . Mol Immunol . 2000;37:1–11
  13. Klausner RD , Samelson LE . T cell antigen receptor activation pathways (The tyrosine kinase connection) . Cell . 1991;64:875–878
  14. Yamashita M , Kimura M , Kubo M , et al.   T cell antigen receptor-mediated activation of the Ras/mitogen-activated protein kinase pathway controls interleukin 4 receptor function and type-2 helper T cell differentiation . Proc Natl Acad Sci U S A . 1999;96:1024–1029
  15. Galli F , Ronco C . Oxidant stress in hemodialysis . Nephron . 2000;84:1–5
  16. Cristol JP , Canaud B , Rabesandratana H , et al.   Enhancement of reactive oxygen species production and cell surface markers expression due to hemodialysis . Nephrol Dial Transplant . 1994;9:389–394
  17. Abe J , Takahashi M , Ishida M , et al.   c-src is required for oxidative stress-mediated activation of big mitogen-activated protein kinase-1 . J Biol Chem . 1997;272:20389–20394
  18. Gonzalez-Rubio M , Voit S , Rodriguez-Puyol D , et al.   Oxidative stress induces tyrosine phosphorylation of PDGF alpha and beta receptors and pp60 c-src in mesangial cells . Kidney Int . 1996;50:164–173
  19. Lo YYC , Wong JMS , Cruz TF . Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases . J Biol Chem . 1996;271:15703–15707
  20. Derijard B , Hibi M , Wu IH , et al.   JNK1 (A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-jun activation domain) . Cell . 1994;76:7352–7362
  21. Angel P , Karin M . The role of Jun, Fos and AP-1 complex in cell proliferation and transformation . Biochim Biophys Acta . 1991;1072:129–157
  22. Kretz-Remy C , Mehlen P , Mirault ME , et al.   Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression . J Cell Biol . 1996;133:1083–1093
  23. Zhang J , Johnston G , Stebler B , et al.   Hydrogen peroxide activates NFkappaB and the interleukin-6 promoter through NFkappaB-inducing kinase . Antioxid Redox Signal . 2001;3:493–504
  24. Seger R , Krebs EG . The MAPK signaling cascade . FASEB J . 1995;9:726–735
  25. Kyriakis JM , Avruch J . Protein kinase cascades activated by stress and inflammatory cytokines . Bioassays . 1996;18:567–577
  26. Brass E , Hoppel C . Energy metabolism (The role of carnitine) . J Care Manage . 1997;3:1–12
  27. Brass EP . Pharmacokinetic consideration for therapeutic use of carnitine in haemodialysis patients . Clin Ther . 1995;17:176–185
  28. Evans AM , Faul R , Fornasini G , et al.   Pharmacokinetics of L-carnitine in patients with end stage renal disease undergoing long term haemodialysis . Clin Pharmacol Ther . 2000;68:238–249
  29. Maeda K , Shinzato T , Kobayakawa H . Effects of L-carnitine administration on short chain fatty acid and long chain fatty acid metabolism during haemodialysis . Nephron . 1989;51:355–361
  30. Suzuky Y , Narita M , Yamazaki N . Effects of L-carnitine on arrhythmias during haemodialysis . Jpn Heart J . 1982;23:349–359
  31. Usberti M , Gerardi G , Gazzotti RM , et al.   Oxidative stress and cardiovascular disease in dialyzed patients . Nephron . 2002;91:25–33
  32. Splitte MA , Hoenic NA , Handelman GJ , et al.   Oxidative stress and inflammation in haemodialysis patients . Am J Kidney Dis . 2001;38:1408–1413
  33. Smogorzewskim M , Perna AF , Borum PR , et al.   Fatty acid oxidation in the myocardium (Effects of parathyroid hormone and CRF) . Kidney Int . 1988;34:797–803
  34. Geremia E , Santoro C , Baratta D , et al.   Antioxidant action of acetyl-L-carnitine (In vitro study) . Med Sci Res . 1988;16:699–700
  35. Sener G , Paskaloglu K , Satiroglu H , et al.   L-carnitine ameliorates oxidative damage due to chronic renal failure in rats . J Cardiovasc Pharmacol . 2004;43:698–705
  36. Koeck T , Kremser K . L-carnitine alters nitric oxide sinthetase activity in fibroblast depending on the peroxisomal status . Int J Biochem Cell Biol . 2003;35:149–156
  37. Pignatelli P , Lenti L , Sanguigni V , et al.   Carnitine inhibits arachidonic acid turnover, platelet function, and oxidative stress . Am J Physiol Heart Circ Physiol . 2002;284:41–48
  38. Vesela E , Racek J , Trefil L , et al.   Effect of L-carnitine supplementation on hemodialysis patients . Nephron . 2001;98:218–223
  39. Matsumoto Y , Sato M , Ohashi H , et al.   Effects of L-carnitine supplementation on cardiac morbidity in haemodialysis patients . Am J Nephrol . 2001;20:201–207
  40. London GM , Drueke TB . Atherosclerosis and arteriosclerosis in chronic renal failure . Kidney Int . 1997;51:1678–1695
  41. Zimmermann J , Herrlinger S , Pruy A , et al.   Inflammation enhances cardiovascular risk and mortality in hemodialysis patients . Kidney Int . 1999;55:648–658
  42. Sakurabayashi T , Takaesu Y , Haginoshita S , et al.   Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients . Am J Nephol . 1999;19:480–484
  43. Miller B , Amads S . A review of impact of L-carnitine therapy on patient functionality in maintenance haemodialysis . Am J Kidney Dis . 2003;41:S44–S48

PII: S1051-2276(04)00237-7

doi: 10.1053/j.jrn.2004.09.031

Journal of Renal Nutrition
Volume 15, Issue 1 , Pages 8-12 , January 2005

Article Tools

* Image Usage & Resolution